National
‘Nigeria has capacity for safe application of modern biotechnology’
6 years ago(FILES) In this file photo taken on August 13, 2020, Biotechnology company Moderna protocol files for Covid-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida. - Moderna, one of two companies currently holding phase 3 trials in the US for a Covid-19 vaccine, took the unusual step on September 17, 2020, of publishing its trial protocols after calls for more transparency. (Photo by CHANDAN KHANNA / AFP)
Director-general of the National Biosafety Management Agency (NBMA), Dr. Rufus Ebegba, has declared that Nigeria has capacity to deploy safe biotechnology products for agricultural development